PTCHD1,也称为Patched domain-containing 1,是一种重要的基因,主要在发育中的大脑和成人大脑组织中表达。近年来,PTCHD1基因突变或缺失已被指出是神经发育障碍(NDs)的候选基因,包括智力障碍(ID)和自闭症谱系障碍(ASD)。PTCHD1编码patched domain-containing protein 1(PTCHD1)蛋白,该蛋白在神经发育和认知功能中发挥着重要作用。
PTCHD1基因位于X染色体上,其突变或缺失可能导致X连锁的神经发育障碍。PTCHD1基因的突变或缺失可能影响神经元的正常发育和功能,导致认知和行为异常。研究表明,PTCHD1基因突变或缺失的患者表现出不同程度的智力障碍和自闭症样症状。此外,PTCHD1基因突变还与睡眠障碍相关,包括非快速眼动睡眠障碍和快速眼动睡眠障碍。
PTCHD1基因的表达受到多个因素的调控。研究发现,PTCHD1基因的启动子区域包含保守的转录因子结合位点,这些位点可能参与调控PTCHD1基因的表达。此外,PTCHD1基因下游存在一个保守的增强子区域,该区域可能对PTCHD1基因的表达起到重要的调节作用。
PTCHD1基因突变或缺失的机制尚未完全清楚。研究发现,PTCHD1基因突变或缺失可能影响蛋白质的N-糖基化和稳定性,进而影响蛋白质的功能和定位。此外,PTCHD1基因突变还可能影响蛋白质与细胞内其他蛋白质的相互作用,进而影响神经发育和认知功能。
PTCHD1基因突变或缺失的研究对神经发育障碍的诊断和治疗具有重要意义。通过深入研究PTCHD1基因的功能和突变机制,可以为神经发育障碍的诊断提供新的分子标志物,并为开发新的治疗方法提供理论基础。
综上所述,PTCHD1基因在神经发育和认知功能中发挥着重要作用。PTCHD1基因突变或缺失可能导致神经发育障碍,包括智力障碍和自闭症谱系障碍。PTCHD1基因的表达受到多个因素的调控,包括启动子区域的转录因子结合位点和下游的增强子区域。PTCHD1基因突变或缺失的机制尚未完全清楚,可能与蛋白质的N-糖基化、稳定性和相互作用有关。深入研究PTCHD1基因的功能和突变机制,对神经发育障碍的诊断和治疗具有重要意义[1][2][3][4][5][6][7][8][9][10]。
参考文献:
1. Montanaro, Federica Alice Maria, Mandarino, Alessandra, Alesi, Viola, Vicari, Stefano, Alfieri, Paolo. 2024. PTCHD1 gene mutation/deletion: the cognitive-behavioral phenotyping of four case reports. In Frontiers in psychiatry, 14, 1327802. doi:10.3389/fpsyt.2023.1327802. https://pubmed.ncbi.nlm.nih.gov/38288059/
2. Pastore, Stephen F, Ko, Sangyoon Y, Frankland, Paul W, Hamel, Paul A, Vincent, John B. 2022. PTCHD1: Identification and Neurodevelopmental Contributions of an Autism Spectrum Disorder and Intellectual Disability Susceptibility Gene. In Genes, 13, . doi:10.3390/genes13030527. https://pubmed.ncbi.nlm.nih.gov/35328080/
3. Pastore, Stephen F, Muhammad, Tahir, Stan, Cassandra, Hamel, Paul A, Vincent, John B. 2023. Neuronal transcription of autism gene PTCHD1 is regulated by a conserved downstream enhancer sequence. In Scientific reports, 13, 20391. doi:10.1038/s41598-023-46673-0. https://pubmed.ncbi.nlm.nih.gov/37990104/
4. Ji, Qi, Li, Si-Jia, Zhao, Jun-Bo, Tan, Jing-Yao, Zhu, Zhi-Ru. 2023. Genetic and neural mechanisms of sleep disorders in children with autism spectrum disorder: a review. In Frontiers in psychiatry, 14, 1079683. doi:10.3389/fpsyt.2023.1079683. https://pubmed.ncbi.nlm.nih.gov/37200906/
5. Xie, Connie T Y, Pastore, Stephen F, Vincent, John B, Frankland, Paul W, Hamel, Paul A. 2024. Nonsynonymous Mutations in Intellectual Disability and Autism Spectrum Disorder Gene PTCHD1 Disrupt N-Glycosylation and Reduce Protein Stability. In Cells, 13, . doi:10.3390/cells13020199. https://pubmed.ncbi.nlm.nih.gov/38275824/
6. Maza, Nycole, Wang, Dandan, Kowalski, Cody, Grill, Brock, Martemyanov, Kirill A. 2022. Ptchd1 mediates opioid tolerance via cholesterol-dependent effects on μ-opioid receptor trafficking. In Nature neuroscience, 25, 1179-1190. doi:10.1038/s41593-022-01135-0. https://pubmed.ncbi.nlm.nih.gov/35982154/
7. Montanaro, Federica Alice Maria, Mandarino, Alessandra, Alesi, Viola, Vicari, Stefano, Alfieri, Paolo. 2024. Corrigendum: PTCHD1 gene mutation/deletion: the cognitive-behavioral phenotyping of four case reports. In Frontiers in psychiatry, 15, 1375954. doi:10.3389/fpsyt.2024.1375954. https://pubmed.ncbi.nlm.nih.gov/38414498/
8. Kiral, Ferdi Ridvan, Cakir, Bilal, Tanaka, Yoshiaki, Xiang, Yangfei, Park, In-Hyun. 2023. Generation of ventralized human thalamic organoids with thalamic reticular nucleus. In Cell stem cell, 30, 677-688.e5. doi:10.1016/j.stem.2023.03.007. https://pubmed.ncbi.nlm.nih.gov/37019105/
9. Rochtus, Anne, Olson, Heather E, Smith, Lacey, Rosen Sheidley, Beth, Poduri, Annapurna. 2020. Genetic diagnoses in epilepsy: The impact of dynamic exome analysis in a pediatric cohort. In Epilepsia, 61, 249-258. doi:10.1111/epi.16427. https://pubmed.ncbi.nlm.nih.gov/31957018/
10. Scala, Marcello, Bradley, Clarrisa A, Howe, Jennifer L, Zara, Federico, Scherer, Stephen W. 2023. Genetic variants in DDX53 contribute to Autism Spectrum Disorder associated with the Xp22.11 locus. In medRxiv : the preprint server for health sciences, , . doi:10.1101/2023.12.21.23300383. https://pubmed.ncbi.nlm.nih.gov/38234782/